Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
38.60
-0.11 (-0.28%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,095,353
Open
38.75
Bid (Size)
38.56 (12)
Ask (Size)
38.91 (12)
Prev. Close
38.71
Today's Range
38.52 - 38.87
52wk Range
33.67 - 45.92
Shares Outstanding
5,385,189,617
Dividend Yield
3.74%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
Today 13:30 EDT
A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher.
Via
InvestorPlace
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
July 08, 2024
Pfizer's RSV vaccine, Abrysvo, for pregnant women shows no increased risk of pre-term births, according to a study. Researchers found no significant difference in pre-term birth rates between...
Via
Benzinga
Performance
YTD
+2.91%
+2.91%
1 Month
-6.51%
-6.51%
3 Month
-5.51%
-5.51%
6 Month
-2.62%
-2.62%
1 Year
+14.03%
+14.03%
More News
Read More
United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win
July 05, 2024
Via
Benzinga
Topics
ETFs
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Via
InvestorPlace
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
July 03, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
July 03, 2024
Via
InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
Via
Benzinga
Exposures
COVID-19
3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
July 03, 2024
Via
The Motley Fool
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
July 02, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
June 27, 2024
Via
Benzinga
Why Is Moderna Stock Trading Lower On Wednesday?
June 26, 2024
Via
Benzinga
Exposures
COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
June 26, 2024
Via
Investor's Business Daily
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Via
Benzinga
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
June 24, 2024
Via
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
June 18, 2024
Via
Benzinga
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
Via
Investor's Business Daily
Exposures
COVID-19
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
June 07, 2024
From
GSK plc
Via
Business Wire
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Large Cap BIopharmaceuticals Overview
June 03, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 03, 2024
Via
InvestorPlace
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.